Pain Medicine · 2014 · 14 citations · 8 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyPain ManagementPain MedicineAnalgesiaNon-opioid AnalgesicsOpioid AnalgesicsOpioid PharmacologyOpioid TherapyOpioid Use DisorderExtended-release OpioidsMetricsMitigation StrategiesOpioid Risk AssessmentOpioid Use EvaluationPrescription Opioid Risk MitigationRisk Mitigation StrategiesSafe Opioid Prescribing
OBJECTIVE: The objective of this study was to develop metrics to assess opioid prescribing behavior as part of the evaluation of the Extended-Release/Long-Acting (ER/LA) Opioid Analgesic Risk Evaluation and Mitigation Strategies (REMS). DESIGN: Candidate metrics were selected using published guidelines, examined using sensitivity analyses, and applied to cross-sectional rolling cohorts of Medicare patients prescribed with extended-release oxycodone (ERO) between July 2, 2006 and July 1, 2011. Potential metrics included prescribing opioid-tolerant-only ER/LA opioid analgesics to non-opioid-tolerant patients, prescribing early fills to patients, and ordering drug screens. RESULTS: Proposed definitions for opioid tolerance were seven continuous days of opioid usage of at least 30 mg oxycodone equivalents, within the 7 days (primary) or 30 days (secondary) prior to first opioid-tolerant-only ERO prescription. Forty-four percent of opioid-tolerant-only ERO episodes met the primary opioid tolerance definition; 56% met the secondary definition. Fills were deemed "early" if a prescription was filled before 70% (primary) or 50% (secondary) of the prior prescription's days' supply was to be consumed. Five percent (primary) and 2% (secondary) of episodes had more than or equal to two early fills during treatment. At least one drug screen was billed in 14% of episodes. Stratified analyses indicated that older patients were less likely to be opioid tolerant at the time of the first opioid-tolerant-only ERO prescription. CONCLUSIONS: Investigators propose three metrics to monitor changes in prescribing behaviors for opioid analgesics that might be used to evaluate the ER/LA Opioid Analgesics REMS. Low frequencies of patients, particularly those >85 years, were likely to be opioid tolerant prior to receiving prescriptions for opioid-tolerant-only ERO.
8
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Roger Chou, Gilbert J. Fanciullo, Perry G. Fine et al. · Journal of Pain · 2009 · 2.2K citations · Full text
Pharmaceutical Overdose Deaths, United States, 2010
Christopher M. Jones, Karin A. Mack, Leonard J. Paulozzi · JAMA · 2013 · 683 citations
Analytic models to identify patients at risk for prescription opioid abuse.
Alan G. White, Howard G. Birnbaum, M. Schiller et al. · PubMed · 2009 · 176 citations